Sterling Biotech reports net loss of Rs 99.38 crore in the September 2013 quarter

Sales decline 18.52% to Rs 161.35 crore

Net Loss of Sterling Biotech reported to Rs 99.38 crore in the quarter ended September 2013 as against net loss of Rs 76.67 crore during the previous quarter ended September 2012. Sales declined 18.52% to Rs 161.35 crore in the quarter ended September 2013 as against Rs 198.02 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales161.35198.02 -19 OPM %16.8724.32 -PBDT-83.76-48.14 -74 PBT-147.11-113.50 -30 NP-99.38-76.67 -30

Powered by Capital Market - Live News